lorlatinib will decrease the level or result of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Stay away from usage of lorlatinib with CYP3A substrates, exactly where nominal concentration modifications could result in major therapeutic fai